MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapySharon Elad, Paolo Bossi|Cancer|2020Cited by 1.3k
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guideFlorian Scotté, Florian Strasser, Paolo Bossi et al.|Annals of Oncology|2018Cited by 169
854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI)Jérôme Fayette, Roger B. Cohen, Lisa Licitra et al.|Annals of Oncology|2023Cited by 32
Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyPaola Queirolo, Francesco Spagnolo, Paolo Bossi et al.|ESMO Open|2023Cited by 16
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyPaola Queirolo, Francesco Spagnolo, Michela Cinquini et al.|ESMO Open|2024Cited by 15